CURRICULUM Department Urological Department Clinic Onze-Lieve-Vrouwziekenhuis Address ...

26 Pages·2008·0.49 MB·English

C U R R I C U L U M

Department Urological Department

Clinic Onze-Lieve-Vrouwziekenhuis

Address Moorselbaan 164
9300 Aalst
Belgium

Tel : [phone]
Fax : [phone]
e-mail : [email protected]

Physicians Dr. FONTEYNE Etienne
Dr. CARPENTIER Paul
Dr. MOTTRIE Alexandre
Dr. SCHATTEMAN Peter

Secretary Ms. EVERAERT Carine

Points of interest (cid:1) laparoscopy
(cid:1) robot-assisted surgery
(cid:1) oncological urology
(cid:1) paediatric urology
(cid:1) female urology
(cid:1) andrology
(cid:1) endourology
(cid:1) prostate centre
(cid:1) stone centre with ESWL
(cid:1) brachytherapy (for prostate cancer)
Professional experience

Dr. Fonteyne Etienne
• 2001-2003 : President of “Belgische Vereniging voor Urologie” (BVU)
• 2000 : Vice-President of “Belgische Vereniging voor Urologie” (BVU)
• since 01/01/1997 : Director of the department of Urology, Onze-Lieve-
Vrouwziekenhuis, Aalst, Belgium
• since 1996 : President of “Regional Quality Control” Group
• since 01/01/1977 : Urologist in Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
• 1977 : Urological degree, Belgium
• 1977 : Urological degree, Netherlands
• 1974 – 1976 : Residency in the department of Urology, Dijkzigt Ziekenhuis
Rotterdam, Netherlands
Director : Prof. N. Bakker
• 1974 : Surgical degree, Belgium
• 1969- 1974 : Residency in the department of General Surgery in University
Hospital Gent, Belgium
Director : Prof. F. Derom
• 1969 : Medical degree, Rijks Universiteit Gent, Belgium

Dr. Carpentier Paul
• Since 2006 : President of National Urological Residency Committee
• Since 2003 : President of “Multidisciplinary Oncological Group Urology, OLV, Aalst”
• Since 2002 : Member of Directory Board “Belgische Beroepsvereniging voor
Urologie” (BBVU)
• Since 1997 : Training coordinator Residency Urology
• Since 01/01/1986 : Urologist in Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
• 1981-1985 : Urological consulting at Radiotherapeutic Institute Rotterdam
• 1981 - 1985 : Chef de clinique of the Department of Urology , Academic Hospital
Rotterdam
Director : Prof Dr. F.H. Schröder.
• 1981 : Urological degree in Belgium and the Netherlands
• 01/09/1978 – 30/08/1981 : Residency at the Department of Urology , Academic
Hospital Rotterdam
Director : Prof Dr. F.H. Schröder
• 01/09/1975 – 30/08/1978 : Residency in the Department of General Surgery,
Kliniek O.L.Vrouw van Lourdes, Waregem
Director : Dr.L.Bouckaert; Dr. D. De Coninck
• 1975 : Medical degree Catholic University of Leuven, Belgium

Dr. Mottrie Alexandre
• Since 2008 : Member of Directory Board of the European Group of Robotic
Urology (EGRU), working group of European Association of Urology (E.A.U.)
• Since 2008 : Founding Member of Directory Board of Society of Urological Robotic
Surgery (S.U.R.S., world society of robotic surgery in Urology)
• Since 2008 : Editorial board of “Journal of Robotic Surgery”.
• Since 2007 : Corresponding Member of Südwestdeutsche Gesellshaft für Urologie
(S.W.D.G.U.)
• Since 2001 : President of President of “Belgian Laparoscopic Urology Group”
(B.L.U.G.)
• Since 01/09/1996 : Urologist in Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
• 1/5/1996 - 1/9/1996 : Clinical fellow in Department of Urology, Washington
University Hospital, St.-Louis, Missouri, U.S.A.
Director : Prof. R. Clayman
• 1994-1996 : Oberarzt in Urological department in Johannes Gutenberg,
Universitätskrankenhaus, Mainz, Germany.
Director : Prof. Dr. R. Hohenfellner
• 21/09/1994 : Urological degree, Belgium
• 29/06/1994 : “Anerkennung als Facharzt für Urologie”, Bezirksärztekammer
Rheinhessen, Deutschland
• 1992-1994 : Residency in Urology in Johannes Gutenberg
Universitätskrankenhaus, Mainz, Germany
Director : Prof. Dr. R. Hohenfellner
• 1988-1992 : Residency in the department of General Surgery and Urology in
Heilig-Hartziekenhuis, Roeselare, Belgium.
Director : Dr. Noyez
• 30/06/1988 : Medical degree, Catholic University of Leuven, Belgium

Dr. Schatteman Peter
• since 01/12/2005: Urologist in Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
• 01/07/2005 – 30/11/2005 : Clinical fellow at Department of Urology, Städtisches
Klinikum, Karlsruhe, Germany (endo-urology and oncological urology)
Director : Prof Dr D Frohneberg
• 01/02/2005 – 30/06/2005 : Clinical fellow at Department of Urology,
Universitätsklinikum Charité Campus Mitte, Berlin, Germany (Laparoscopic
urology)
Director : Prof Dr S Loening
• 01/09/2004 – 31/01/2006 : Clinical fellow at Department of Oncological Urology,
IUNA, Fundacio Puigvert, Barcelona, Spanje (oncological urology)
Director : Prof Dr J Palou & Prof Dr H Villavicencio
• 08/2004 : Urological degree, Belgium
• 2001 – 2004 : Residency in the Urological Department, Onze-Lieve-
Vrouwziekenhuis, Aalst
Director : Dr. E. Fonteyne
• 1998-2001 : Residency in the Surgical Department, AZ Middelheim, Antwerp
Director : Dr. Y. Gerard
• 06/1998 : Medical degree, University of Antwerp, Belgium
• 03 – 05/1997 : Training Gynecology – Urology, Cape Town, South-Africa
Memberships

Dr. Fonteyne Etienne
• Fellow of the “European Board of Urology” (FEBU)
• Member of the “European Association of Urology” (EAU)
• Member of the “Deutsche Gesellschaft fur Urologie” (DGU)
• Member of the “Société Internationale d’Urologie” (SIU)
• Member of the “Belgian Association of Urology” (BAU)
• Member of the “Belgische Vereniging voor Urologie” (BVU)
• Member of the “Société Belge d’Urologie” (SBU)
• Member of the “Belgische Beroepsvereniging voor Urologie” (BBVU)

Dr. Carpentier Paul
• Fellow of the “European Board of Urology” (FEBU)
• Active Member of the European Organisation for Research and
Treatment of Cancer (EORTC)
• Member of the “European Association of Urology” (EAU)
• Member of the “Belgian Association of Urology” (BAU)
• Member of the “Belgische Vereniging voor Urologie” (BVU)
• Member of the “Dutch Association of Urology” (NVU)
• Member of the “American Association of Urology” (AUA)
• Member of the “Société Internationale d’Urologie” (SIU)
• Member of the “Association Française d'Urologie » (AFU)
• Member of the “Société Belge d’Urologie” (SBU)
• Member of the “Belgische Beroepsvereniging voor Urologie” (BBVU)
• President of National Urological Residency Committee

Dr. Mottrie Alexandre
• Member of “European Association of Urology” (E.A.U.)
• Member of “Deutsche Gesellshaft für Urologie” (D.G.U.)
• Member of the “Belgian Association of Urology” (BAU)
• Member of “Belgische Vereniging voor Urologie” (B.V.U.)
• Member of the “Belgische Beroepsvereniging voor Urologie” (BBVU)
• Member of the “European Group of Robotic Urology” (E.G.R.U.)
• President of “Belgian Laparoscopic Urology Group” (B.L.U.G.)
• Corresponding member of the “Südwestdeutsche Gesellschaft für
Urologie”(SWDGU)

Dr. Schatteman Peter
• Fellow of the “European Board of Urology” (FEBU)
• Member of “European Association of Urology” (E.A.U.)
• Member of the “Belgian Association of Urology” (BAU)
• Member of “Belgische Vereniging voor Urologie” (B.V.U.)
• Member of the “Belgische Beroepsvereniging voor Urologie” (BBVU)
• Member of “Belgian Laparoscopic Urology Group” (B.L.U.G.)
Original publications

1. A. Mottrie, G. De Naeyer, P. Van Migem, P. Schatteman, P. Carpentier, E.
Fonteyne: Pure robot assisted psoas hitch ureteral reimplantation for distal
ureteral stenosis. Video accepted for publication in European Urology Video
Journal.

2. A. Mottrie, G. De Naeyer, P. Van Migem, P. Schatteman, P. Carpentier, E.
Fonteyne: Total interfascial robot assisted prostatectomy. Video accepted for
publication in European Urology Video Journal.

3. G. De Naeyer, P. Van Migem, P. Schatteman, P. Carpentier, E. Fonteyne, A.
Mottrie: „Robotic assistance in urological microsurgery: initial report of a
successful in vivo robot assisted vasovasostomy“, J Robotic Surg 2007; 1:161–
162

4. G. De Naeyer, P. Van Migem, P. Schatteman, P. Carpentier, E. Fonteyne, A.
Mottrie: „Pure robot-assisted psoas hitch ureteral reimplantation for distal
ureteral stenosis“, J. Endourol. 2007; 21(6):618-620.

5. A. Mottrie, P. Schatteman, P. Carpentier, E. Fonteyne, S. Siemer, M. Stöckle :
"Robot-assisted laparoscopic radical cystectomy : initial experience on 27
consecutive patients", Journal of robotic surgery, accepted for publication

6. P Schatteman, P Van Migem, P Willemsen, G De Naeyer, P Carpentier, E
Fonteyne, A Mottrie: Gerobotiseerde laparoscopische radicale prostatectomie :
oncologische en functionele resultaten. De Agenda Andrologie 2007, 9:28-31

7. Schatteman P., Chatzopoulos C., Assenmacher C., Visscher L., Jorion J., Blaze
V., Van Cleynenbreugel B., Billiet I., Van der Eecken H., Bollens R., Mottrie A. :
“Laparoscopic Nephroureterectomy for Upper Urinary Tract Transitional Cell
Carcinoma: Results of a Belgian Retrospective Multicentre Survey.” Eur Urol.
2007 Jun;51(6):1633-8; discussion 1638.

8. A. Mottrie, P. Van Migem, G. De Naeyer, P. Schatteman, P. Carpentier, E.
Fonteyne : „Robot-assisted laparoscopic radical prostatectomy : Oncologic and
functional Results of 184 Cases” Eur Urol. 2007 Sep;52(3):746-50.

9. A. Mottrie, R. Bürger, Voges G. E., Baert L. “Die antegrade-skrotale
Sklerotherapie der Varicocele testis“ Akt. Urol. 2007, 38(2):167-73

10. J Palou, P Schatteman, J Huguet, J Segarra, F Algaba, H Villavicencio:
Intravesical instillations with bacillus Calmette-Guerin for treatment of
superficial transitional cell carcinoma involving prostatic ducts. Eur Urol. 2006
May;49(5):834-8; discussion 838

11. Tuytten T., Mottrie A., Van Migem P., Carpentier P., Fonteyne E.
“Robotgeassisteerde laparoscopische prostatectomie: perfectioneren van een
minimaal invasieve techniek.” Ned T Gen, Vol 14, Nr 5: 153-158. 2006

12. Dhondt E, Tuytten T, Fonteyne E, Van Gysel D. Acute idiopathic scrotal oedema
in children. Tijdschrift voor Geneeskunde 2006, vol 62 (18), 1300-1303

13. T. H. de Reyke, K. H. Kurth, R. J. Sylvester, R.R Hall, M. Brausi, K van de Beek,
K. E. J Landsoght, P. Carpentier and menbers of the EORTC-GU Group. BCG
versus Epirubicinh in carcinoma in situ of the bladder: Results of an EORTC-GU
Group phase III trial (30906). J Urol 2005; 173: 405-409
14. A. Mottrie, P. Martens, R. Bollens, et al. “Laparoskopische Kolposakropexie”
Akt. Urol. 2005; 36: 157-168

15. P. Schatteman, T. Tuytten, P. Carpentier, E. Fonteyne, A. Mottrie.
“Laparoscopische benadering van het niercelcarcinoom: oncologisch
verantwoord?” T.Geneesk. 2005,vol61,nr3:179-184

16. P. Schatteman, H. Vandereecken, P. Carpentier, E. Fonteyne, A. Mottrie. “De
orthotope neoblaas na cystectomie : superieure derivatie voor de patient?”
T.Geneesk. 2004,vol60,nr9:621-625

17. K.H. Kurth, T.H.M. De Reijke, R. Sylvester, R.R. Hall, M. Brausi, C. Van De
Beek, K.E.J. Landsoght, P. Carpentier. BCG vs Epirubicin in carcinoma in situ of
the bladder: results of an EORTC GU Group phase III trial (30906). BJU Int
2004; 94 Suppl 2: 29 (abstract PD-2.04).

18. van Andel G, Fernandez de Moral P, Caris CT, Carpentier P, Wils J, de Bruin MJ,
Witjes JA, Debruyne FM, Witjes WP.. A randomized study comparing epirubicin
in a 4-weekly versus a weekly intravenous regimen in patients with metastatic,
hormone resistant, prostatic carcinoma: effects on health related quality of life.
World J Urol. 2003 Aug;21(3):177-82

19. Van der Eecken H., P. Schatteman, P. Carpentier, E. Fonteyne, A. Mottrie.
“Major intraabdominal complications following ESWL in a patiënt with Ehlers-
Danlos Syndrome” Eur Urol. 2002,42,635-636

20. Van der Eecken H., P. Schatteman, A. Mottrie, P. Carpentier, E. Fonteyne.
“laparoscopische sacropexie : een nieuwe, weinig invasieve techniek voor de
behandeling van een verzakking bij de vrouw” T.Geneesk.
2003,vol59,nr12:789-793

21. P Schatteman, P Willemsen, M Vanderveken, F Lockefeer, A Vandebroek:
Skeletal muscle metastasis from a conventional renal cell carcinoma, two years
after nephrectomy: a case report. Acta Chirurgica Belgica 2002; 102: 351-352

22. Van der Eecken H., A. Mottrie, P. Carpentier, E. Fonteyne. “laparoscopische
nefrectomie : ervaringen met de eerste 50 patiënten” T.Geneesk.
2002,vol58,nr4:251-255

23. Jakse, G., Hall, R., Bono, A., Hôtl, W., Carpentier, P., Spaander,J.P., van der
Meyden.A.P.M., M., Sylvester, R. and members of the EORTC GU- Group:
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: Long
term results of EORTC GU Group PHASE II Protocol 30861. European Urology,
2001;40: 144-150

24. P. Martens, E. Fonteyne, A. Mottrie, V. Morelle, P. Carpentier “Controverse
transurethrale resectie van de prostaat (TURP) en antibioticaprophyllaxe :
eigen ervaringen” T.Geneesk., 57, nr5, 2001, 353-358

25. P Schatteman, L Hoekx, JJ Wyndaele, W Jeuris, E Van Marck: Inflammation in
prostatic biopsies of men without prostatic malignancy or clinical prostatitis.
Correlation with total serum PSA and PSA density. European Urology 2000; 37:
404-412
26. J.Baert, P.Carpentier, R.Blanca Garcia, G. Rolly. Hyperbaric oxygen treatment
for radiation ulcer of the bladder. British Journal of Urology (1998), 81, 929-
930.

27. Buzelin JM, Fonteyne E, Kontturi M, Witjes WP, Khan A. Comparison of
tamsulosin with alfuzosin in the treatment of patients with lower urinary tract
symptoms suggestive of bladder outlet obstruction (symptomatic benign
prostatic hyperplasia). The European Tamsulosin Study Group. Br J Urol. 1997
Oct;80(4):597-605

28. Splinter TA, Pavone-Macaluso M, Jacqmin D, Roberts JT, Carpentier P, de Pauw
M, Sahmoud T. Genitourinary group phase II study of chemotherapy in stage
T3-4 N0-X M0 transitional cell cancer of the bladder: prognostic factor analysis.
Eur J Cancer. 1996 Jun;32A (7):1129-34.

29. A.M. Mottrie, Y. Matani, J. Fichtner, G.E. Voges and R. Hohenfellner :
Transurethral prostatectomy of the prostate : a long term follow-up in 176
patients over 80 years of age. Eur. Urol. , 1996

30. J. Fichtner D. Filipas, A.M. Mottrie, G.E. Voges and . Hohenfellner : Analysis of
meatal location in 500 men : wide variation questions need for meatal
advancement in all pediatric anterior hypospadias cases. J. Urol., 154,833-
834, 1995.

31. G.E. Voges, A.M. Mottrie, J. Fichtner, C. Mappes, S. Störkel, M. Stöckle and R.
Hohenfellner : Maximum Androgan Deprivation prior to Radical Prostatectomy
in Patients with Stage T3 Adenocarcinoma of the Prostate. Eur. Urol. 28 : 209-
14,1995.

32. A.M. Mottrie , Y. Matani, J. Baert, G.E. Voges and R Hohenhefner : Antegrade
scrotal sclerotherapy for the treatment of varicocele in childhood and
adolescence Urology Digest, 2 : 15-16, 1995

33. A.M. Mottrie, Y. Matani, J. Baert, G.E. Voges and R. Hohenfellner : Antegrade
scrotal sclerotherapy for the treatment of varicocele in childhood and
adolescence.Br. J. Ur. 76: 21-24, 1995.

34. De Groote P, Baert J, Carpentier P, Fonteyne E, Morelle V. Antegrade scrotal
sclerotherapy in the treatment of varicocele Acta Urol Belg. 1995;63(2):57-
62

35. Splinter T.A.W., Pavone-Macaluso M., Jacqmin D., Roberts J.T., Carpentier P.,
De Pauw M., and Sylvester R. An EORTC GU Group phase II study of
neoadjuvant chemotherapy in T3-4N0-XM0 bladder cancer: multivariate
analysisi of prognostic factors. Proc. AACR, 1993 ( abs. 1354).

36. Voges G.E., Mottrie A.M., Stöckle M., Müller S.C. : Hormone therapy prior to
radical prostatectomy in patients with clinical stage C prostate cancer. Prostate
Suppl. 1994;5:4-8.

37. K.M. Essig, W.J. Mayet, A.M. Mottrie, I. Helmreich-Becker, K.H. Meyerzum
Buschenfelde : Rheumatoid nodules located in the penis of a methotrexate-
treated patient with rheumatoid arthritis. Z. Rheumatol, 53(5), 314-6, 1994.

38. A.M. Mottrie, R. Bürger, G.E. Voges, L. Baert, R. Hohenfellner : Die antegrade-
skrotale Sklerotherapie der Varicocele testis. Akt. Urol., 25: I – VI, 1994.
39. J. Baert, A.M. Mottrie, J. Braeckman, JL. Van Houcke : De antegrade
sclerosering : een nieuwe behandelingsmethode van de varicocele. Belgisch
tijdschrift voor Geneeskunde, 1994.

40. P. Albers, G.E. Voges, A.M. Mottrie, R. Moll and R. Hohenfellner : Der
vermeintlich extragonadale Keimzelltumor : Akt. Urol. 25: 111-113, 1994.

41. Verbaeys A, Carpentier P, Cuvelier C, Praet M, Fonteyne E, Morelle V, De Sy
WA. Down-staging prostate cancer. Is it possible by androgen depletion and
Mitomycin C therapy? Acta Urol Belg. 1993;61(4):1-4

42. B. Dillemans, A.M. Mottrie, Decoster M. and Gruwez J.A.: Epidermoid cysts of
the spleen. Acta chir. Belg. (impact factor: 0.298), 93(6), 265-7, 1993.

43. Splinter TA, Pavone-Macaluso M, Jacqmin D, Roberts JT, Carpentier P, de Pauw
M, Sylvester R. A European Organization for Research and Treatment of
Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-
XM0 transitional cell cancer of the bladder: evaluation of clinical response. J
Urol. 1992 Dec;148 (6):1793-6.

44. Sneller, Z.W, Hop, W.C.J., Carpentier, P. and Schröder, F.H. Prognosis and
prostatic volume change during endocrine management of prostatic cancer
patients - a longitudinal study. Journal of Urology: 147, pp962-966, 1992

45. Jakse, G., Hall, R., Bono., A., Holtl, W., Carpentier, P., De Pauw, M., Sylvester,
R.. BCG treatment in Tis of the urinary bladder, results of the EORTC Protocol
30861. EORTC GU Group. Prog. Clin. Biol. Res. 378: 69-74, 1992.

46. Baekelandt M, D'Haenens P, Wynant H, Fonteyne E, Stockx L, Leyman P. Occult
prostatic abscess detected by transrectal sonography and computed
tomography. J Belge Radiol. 1991;74(3):217-9

47. Kurth, K.H., Vijgh WJ., ten Kate, F. , Bogdanowicz JF., Carpentier, P.J, Van
Reyswoud I. Phase 1/2 study of intravesical epirubicin in patients with
carcinoma in situ of the bladder. J Urol.1991 Dec; 146(6): 1508-12; discussion
1512-

48. Wynant HP, Morelle V, Fonteyne E, Carpentier P. Ureterosigmoidostomy:
reevaluation of a "forgotten" continent urinary diversion. Acta Urol Belg.
1991;59(4):103-7

49. Kurth, K.H., Mross, K., ten Kate, F. , Weissglas, G., Carpentier, P.J., Boeken
Kruger, C.G.D.,Blom J, Groen,J.M., Van Caubergh, R.D., Van Aubel, O., et al, I.
Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of
the bladder. Prog Clin Biol Res.1990; 350; 41-59

50. Kurth, K.H., Mross, K., ten Kate, F. , Weissglas, G., Carpentier, P.J., Boeken
Kruger, C.G.D., Green,J.M., Van Caubergh, R.D., Van Aubel, O., Van Reyswoud,
I. : Phase I/II study of intravesical epirubicin in patients with carcinoma in situ
of the bladder. Uro-oncology : current status and future trends, p41-45, 1990

51. Splinter TA, Jacqmin D, Roberts JT, Pavone-Macaluso M, de Pauw M, Sylvester
R, Carpentier P. EORTC Group Study 30851 : a phase II study of neoadjuvant
chemotherapy in patients with invasive bladder cancer. Prog Clin Biol Res.
1990; 353: 213-217
52. Wynant HP, Morelle V, Fonteyne E, Carpentier P. Multiple ureteral diverticula:
report of 2 cases and review of the literature. Eur Urol. 1990;18(4):309-10

53. Van Haverbeke J, Morelle V, Fonteyne E. Basket extraction--its place in the
current treatment of the lower ureteric stone: clinical experience. Eur Urol.
1987;13(4):233-7

54. Lornoy W, Becaus S, de Vleeschouwer M, Morelle V, Fonteyne E, Thienpont L,
Mestdagh J. Renal cell carcinoma, a new complication of analgesic nephropathy.
Lancet 1986 May 31;1(8492):1271-2

55. Carpentier, P.J.., Schröder, F.H. and Schmitz, P.I.M. Transrectal
ultrasonametrie of the prostate: The prognostic relevance of volume changes
under endocrine management. World J. Urol. 4: 159-162, 1986

56. Kurth, K.H., Daleiso, O., de Pauw, M., Ay, R., Carpentier, P.J. und Mitglieder
der EORTC-GU-Gruppe : Welche oberflächlichen Uberganszellkarzinome der
Harnblase solten adjuvant chemotherapeutisch behandelt werden? Akt. Urol.
16, 87-90, 1985

57. Oosterlinck W, Fonteyne E, Casselman J, Morelle V, Minnaert H, De Sy WA.
Experience with percutaneous stone manipulation. Comparison between early
and later results. Acta Urol Belg. 1985;53(3):501-6

58. Carpentier, P.J. and Schröder, F.H.: Transrectal ultrasonography in the follow-
up of prostatic carcinoma patients: a new prognostic parameter. Journal of
Urology, 131: 903-905, 1984.

59. E. Wespes, E.Fonteyne, C.C.Schulman. Blind duplication of the Ureter. World J
Urol. (2) 1984, 269-271

60. N.Verleyen, V.Morelle, E. Fonteyne, A. Daeneindt, P.D'Haenens, R.Van
Steenberge. Die Vorteile des C.T. Skanners bei der Beurteilung von vaskulären
Niern Abweichungen. Jaarboek Deutschen Gesellschaft für Urologie (1983)
Urologe A

61. Carpentier, P.J., Kurth, K.H., Blom, W. and Huijsmans, J.G.M.: Heterozygous
Cystinuria and Calcium Oxalate Urolithiasis. Journal of Urology, 130: 302-304,
1983.

62. Thienpont L, Mestdagh J, Morelle V, Fonteyne E, De Galan JL, Lornoy W, Becaus
I. Current practice of urinary cytology. A four-year-practice review with 3,995
cytological specimens examined. Acta Urol Belg.1983;51(1):18-30

63. W.lornoy, I.Becaus, V.Morelle, E.Fonteyne, L.Thienpont, J.Mestdagh, A. Rollier,
R.Van Steenberge, P.D'Haenens. Een geval van bilaterale pyelumtumor bij een
patiënt met analgetica-nephropathie. Tijdschrift voor Geneeskunde 1983, vol
39 (2)

64. Carpentier, P.J., Bettinck, P.J., Hop, W.C.J. and Schröder, F.H.: Reflux: a
retrospective study of 100 ureteral reimplantations by the Politano-Leadbetter
method and 100 by the Cohen technique. Br. J. of Urology 54: 230-233, 1982.

65. Carpentier, P.J., Schröder, F.H. and Blom, J.H.M.: Transrectal ultrasonography
in the follow- up of prostatic carcinoma patiënts. Journal of Urology, 128: 742-
746, 1982.
66. Morelle VR, Fonteyne EJ. The use of the renal capsule in renal and ureteric
surgery. Br J Urol. 1981 Oct;53(5):403-5

67. Carpentier, P.J., Schlattmann, T.J.M. und Schröder, F.H.: Transrektaler
Ultraschall - ein Parameter zur Beurteilung des Therapie - Erfolges beim
Prostatakarzincom ? Verhandlungsbericht der Deutschen Gesellschaft für
Urologie, 32. Tagung: 94-98, 1980.

68. V. Morelle, E. Fonteyne. Les indications de la pyéloscopie. J Urol.
1980;86(10):751

69. V. Morelle, E. Fonteyne. La technique de la pyéloscopie. J Urol.
1980;86(10):751

70. Morelle V, Fonteyne E.Use of a procedure for vesical mobilisation in conditions
affecting the lower urethra. J Urol 1980;86(4):261-6

71. Lornoy W, Morelle V, Becaus I, Fonteyne E, Mestdagh J, Thienpont L, Rollier A,
Van Steenberge R, D'Haenens P. Malignant uroepithelial tumors of the
upper urinary tract in sixteen patients with analgesic nephropathy. Acta Clin
Belg. 1980;35(3):140-7

72. Kurth, K.H., Carpentier, P.J., Alleman, E.R.J et Schröder, F.H.: "Undiversion" et
réconstruction des voies urinaires chez des enfants ayant des déviations
urinaires. Journal d' Urologie et Neprhrologie 85 (2): 248-251, 1979.

73. Schlattman, T.J.M., Carpentier, P.J., Schröder, F.H.:Transrektaler Ultraschall
und CT-scan bei der Grössenbestimmung des Prostataadenoms und andere
Tumoren des kleinen Beckens. Verhandlungsbericht der Deutschen Gesellschaft
für Urologie, 31. Tagung: 515-517, 1979.

74. Carpentier, P.J. Bettinck, P.J., Hop, W.C.J., Schröder, F.H.: Reflux -
Nachuntersuchung von je 100 nach Politano-Leadbetter und 100 nach Cohen
operieten Kindern. Verhandlungsbericht der Deutschen Gesellschaft für
Urologie, 31. Tagung: 198-200, l979

75. W.Lornoy, V. Morelle, I.Becaus, E.Fonteyne. Het ontstaan van Maligne
tumoren in de urinaire tractus bij patiënten met analgetische nefropathie. T
Geneesk. 1979, vol 59 (12), 795

76. V. Morelle, E. Fonteyne. Het gebruik van nierkapselplastie in de bovenste
urinewegen. Ned T voor Geneeskunde, 1979, 51

77. E.Fonteyne, V.Morelle. Ervaringen met 100 pyelocalicoscopieën. Ned T voor
Geneeskunde, 1979, 51

78. W.Lornoy, V.Morelle, E.Fonteyne, I.Becaus. The development of malignant uro-
epithelial tumors in the upper ureter urinary trect in patients with analgesic
associated nephropathy (AAN). Clinical findings in 16 patients. Kidney
International 16, 1979, 97

79. V. Morelle, W. Lornoy, E. Fonteyne, I. Becaus. La tumeur pyélo-urétérale et la
lithiase coralliforme sur rein unique après abus de phénacétine. J Urol Nephrol.
1979 Sep; 85(9):273-274

80. Lornoy W, Morelle V, Becaus I, Fonteyne E. Development of malignant
uroepithelial neoplasms in the upper urinary tracts in nephropathies caused by